BioSig Technologies Inc (NASDAQ:BSGM) saw a large drop in short interest in the month of May. As of May 15th, there was short interest totalling 2,460,000 shares, a drop of 8.9% from the April 30th total of 2,700,000 shares. Based on an average trading volume of 763,800 shares, the short-interest ratio is currently 3.2 days. Approximately 12.7% of the shares of the company are sold short.
Large investors have recently bought and sold shares of the business. Advisor Group Holdings Inc. purchased a new position in BioSig Technologies during the 1st quarter valued at about $31,000. Oxford Asset Management LLP purchased a new stake in shares of BioSig Technologies during the fourth quarter worth about $64,000. Private Advisor Group LLC grew its holdings in shares of BioSig Technologies by 30.0% during the fourth quarter. Private Advisor Group LLC now owns 13,000 shares of the company’s stock worth $77,000 after buying an additional 3,000 shares in the last quarter. Barclays PLC grew its holdings in shares of BioSig Technologies by 105.0% during the fourth quarter. Barclays PLC now owns 15,863 shares of the company’s stock worth $94,000 after buying an additional 8,124 shares in the last quarter. Finally, Parametric Portfolio Associates LLC purchased a new stake in shares of BioSig Technologies during the first quarter worth about $112,000. Hedge funds and other institutional investors own 14.28% of the company’s stock.
Several analysts have recently commented on the stock. BidaskClub cut shares of BioSig Technologies from a “buy” rating to a “hold” rating in a research note on Friday. Zacks Investment Research upgraded shares of BioSig Technologies from a “hold” rating to a “buy” rating and set a $12.00 price objective for the company in a research note on Friday. ValuEngine upgraded shares of BioSig Technologies from a “hold” rating to a “buy” rating in a research note on Wednesday, April 1st. Finally, Roth Capital assumed coverage on shares of BioSig Technologies in a research note on Monday, March 30th. They issued a “buy” rating and a $9.00 price objective for the company.
BioSig Technologies (NASDAQ:BSGM) last posted its earnings results on Monday, May 11th. The company reported ($0.46) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.24) by ($0.22). As a group, research analysts expect that BioSig Technologies will post -0.9 earnings per share for the current fiscal year.
About BioSig Technologies
BioSig Technologies, Inc, a development stage medical device company, engages in developing a proprietary biomedical signal processing technology platform to extract information from physiologic signals. Its product is PURE (Precise Uninterrupted Real-time evaluation of Electrograms) EP System, a surface electrocardiogram and intracardiac multichannel recording and analysis system that acquires, processes, and displays electrocardiogram and electrograms required during electrophysiology studies and catheter ablation procedures.
Featured Article: What is the LIBOR?
Receive News & Ratings for BioSig Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioSig Technologies and related companies with MarketBeat.com's FREE daily email newsletter.